Clinical Trial Update: A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 [NA]

View source ↗

Summary

A long-term safety surveillance study of participants previously treated with 177Lu-IPN01072 has been completed, monitoring safety outcomes in neuroendocrine tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• 177Lu-IPN01072

Snippet

Sponsor: Ariceum Therapeutics GmbH | Conditions: Neuroendocrine Tumors | NA | Status: COMPLETED